Delivery Order SPE2DR25D3005-SPE2DR26FP8DY
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringes. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $5,364.04 and is scheduled for completion by December 11, 2025. The award is not set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in syringe form (0.5mL) with a ceiling value of $1,064.40. This competitively awarded, firm fixed-price delivery order was issued on July 23, 2025, with an ultimate completion date of July 24, 2025. The contract utilizes no set-aside designation and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a $5,066.71 delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Boostrix TDAP vaccine in 0.5 mL syringes. The contract, designated as a firm fixed-price delivery order with an ultimate completion date of December 3, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation and represents a child contract issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Boostrix TDAP vaccine in 0.5ML syringes. This competitively awarded, non-set-aside contract carries a ceiling value of $1,865.25 with a firm fixed price structure and an ultimate completion date of September 2, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a transactional...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringes, with a ceiling value of $13,188.24. This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation, indicating open competition among...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in syringe form (0.5mL) valued at $1,863.95 under a firm fixed price contract. The award was made on August 20, 2025, with an ultimate completion date of August 21, 2025, and represents a non-set-aside competitive award. Performance of this delivery order will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in 0.5ml syringe format, valued at $23,850.60 under a firm fixed-price contract type. The award was made on February 3, 2025, with an ultimate completion date of February 4, 2025, and represents a non-set-aside competitive award. Performance will be executed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Boostrix TDAP vaccine syringes (0.5mL) with a ceiling value of $13,571.10. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is expected to be completed by May 13, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. This delivery order represents a task under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Boostrix TDAP vaccine in 0.5ML syringes. This competitively awarded, firm fixed-price contract carries a ceiling value of $2,053.23 and an ultimate completion date of October 22, 2025. The order will be fulfilled from AmerisourceBergen's operations in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in 0.5mL syringes, with a contract ceiling value of $3,691.24. The award was executed on July 22, 2025, with an ultimate completion date of July 23, 2025, utilizing firm fixed-price pricing on a competitive, non-set-aside basis. Performance will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- SPE2DR25D3005Indefinite Delivery Contract
- SPE2DR25D3005-SPE2DR26FP8DYDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine syringes (0.5mL) with a ceiling value of $1,818.55. This contract was awarded on December 22, 2025, with an ultimate completion date of December 23, 2025, and utilizes firm fixed price pricing. The award is not set-aside and represents competitive procurement through the federal system. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime indefinite delivery vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract encompasses specialty medications, brand-name and generic drugs, vaccines, syringes, and medical supplies across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 12/21/25 |